Generation Bio Stock Forward View
| GBIO Stock | USD 5.59 0.02 0.36% |
Generation Stock outlook is based on your current time horizon. Although Generation Bio's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Generation Bio's systematic risk associated with finding meaningful patterns of Generation Bio fundamentals over time.
As of today, The RSI of Generation Bio's share price is at 52. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Generation Bio, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (10.20) | EPS Estimate Current Year (2.46) | EPS Estimate Next Year (7.75) | Wall Street Target Price 5.25 | EPS Estimate Current Quarter (30.00) |
Using Generation Bio hype-based prediction, you can estimate the value of Generation Bio Co from the perspective of Generation Bio response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Generation Bio Co on the next trading day is expected to be 5.73 with a mean absolute deviation of 0.1 and the sum of the absolute errors of 6.13. Generation Bio after-hype prediction price | USD 5.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Generation | Build AI portfolio with Generation Stock |
Generation Bio Additional Predictive Modules
Most predictive techniques to examine Generation price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Generation using various technical indicators. When you analyze Generation charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Generation Bio Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Generation Bio's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2019-03-31 | Previous Quarter 49.1 M | Current Value 21.9 M | Quarterly Volatility 133.6 M |
Generation Bio Naive Prediction Price Forecast For the 1st of February
Given 90 days horizon, the Naive Prediction forecasted value of Generation Bio Co on the next trading day is expected to be 5.73 with a mean absolute deviation of 0.1, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.13.Please note that although there have been many attempts to predict Generation Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Generation Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Generation Bio Stock Forecast Pattern
| Backtest Generation Bio | Generation Bio Price Prediction | Buy or Sell Advice |
Generation Bio Forecasted Value
In the context of forecasting Generation Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Generation Bio's downside and upside margins for the forecasting period are 3.56 and 7.90, respectively. We have considered Generation Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Generation Bio stock data series using in forecasting. Note that when a statistical model is used to represent Generation Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.8684 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0989 |
| MAPE | Mean absolute percentage error | 0.0184 |
| SAE | Sum of the absolute errors | 6.1346 |
Predictive Modules for Generation Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Generation Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Generation Bio After-Hype Price Density Analysis
As far as predicting the price of Generation Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Generation Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Generation Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Generation Bio Estimiated After-Hype Price Volatility
In the context of predicting Generation Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Generation Bio's historical news coverage. Generation Bio's after-hype downside and upside margins for the prediction period are 3.41 and 7.75, respectively. We have considered Generation Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Generation Bio is somewhat reliable at this time. Analysis and calculation of next after-hype price of Generation Bio is based on 3 months time horizon.
Generation Bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Generation Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Generation Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Generation Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 2.17 | 0.01 | 0.13 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.59 | 5.58 | 0.18 |
|
Generation Bio Hype Timeline
Generation Bio is currently traded for 5.59. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.13. Generation is forecasted to decline in value after the next headline, with the price expected to drop to 5.58. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.18%, whereas the daily expected return is currently at 0.12%. The volatility of related hype on Generation Bio is about 203.52%, with the expected price after the next announcement by competition of 5.72. About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Generation Bio recorded a loss per share of 9.37. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 22nd of July 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Historical Fundamental Analysis of Generation Bio to cross-verify your projections.Generation Bio Related Hype Analysis
Having access to credible news sources related to Generation Bio's direct competition is more important than ever and may enhance your ability to predict Generation Bio's future price movements. Getting to know how Generation Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Generation Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GILD | Gilead Sciences | 2.01 | 9 per month | 1.34 | 0.11 | 3.01 | (2.41) | 6.70 | |
| SNY | Sanofi ADR | 0.22 | 9 per month | 0.00 | (0.18) | 1.87 | (2.19) | 5.92 | |
| AMGN | Amgen Inc | 2.92 | 8 per month | 1.17 | 0.12 | 3.47 | (2.59) | 11.18 | |
| GSK | GlaxoSmithKline PLC ADR | (0.41) | 10 per month | 1.31 | 0.07 | 2.38 | (2.17) | 8.39 | |
| BMY | Bristol Myers Squibb | 3.37 | 10 per month | 1.04 | 0.16 | 3.59 | (1.98) | 11.16 | |
| SYK | Stryker | 2.19 | 9 per month | 0.00 | (0.12) | 1.65 | (2.03) | 6.72 | |
| BSX | Boston Scientific Corp | (0.63) | 8 per month | 0.00 | (0.13) | 1.73 | (2.23) | 7.34 | |
| NVO | Novo Nordisk AS | (1.14) | 6 per month | 2.02 | 0.05 | 5.80 | (3.04) | 13.19 |
Other Forecasting Options for Generation Bio
For every potential investor in Generation, whether a beginner or expert, Generation Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Generation Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Generation. Basic forecasting techniques help filter out the noise by identifying Generation Bio's price trends.Generation Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Generation Bio stock to make a market-neutral strategy. Peer analysis of Generation Bio could also be used in its relative valuation, which is a method of valuing Generation Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Generation Bio Market Strength Events
Market strength indicators help investors to evaluate how Generation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Generation Bio shares will generate the highest return on investment. By undertsting and applying Generation Bio stock market strength indicators, traders can identify Generation Bio Co entry and exit signals to maximize returns.
Generation Bio Risk Indicators
The analysis of Generation Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Generation Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting generation stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.64 | |||
| Standard Deviation | 2.26 | |||
| Variance | 5.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Generation Bio
The number of cover stories for Generation Bio depends on current market conditions and Generation Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Generation Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Generation Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Generation Bio Short Properties
Generation Bio's future price predictability will typically decrease when Generation Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Generation Bio Co often depends not only on the future outlook of the potential Generation Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Generation Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.7 M | |
| Cash And Short Term Investments | 185.2 M |
Check out Historical Fundamental Analysis of Generation Bio to cross-verify your projections. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Will Biotechnology sector continue expanding? Could Generation diversify its offerings? Factors like these will boost the valuation of Generation Bio. Market participants price Generation higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Generation Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (9.37) | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
Generation Bio's market price often diverges from its book value, the accounting figure shown on Generation's balance sheet. Smart investors calculate Generation Bio's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Generation Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.